HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ONC-107

proprietary preparation obtained by extraction of Chlorella pyrenoidosa cells that selectively boost antibody response to the influenza vaccine; the bulk of the immunostimulatory activity resides in polysaccharide/protein complexes with molecular masses larger than 100 kDa that are composed primarily of galactose, rhamnose and arabinose; in human clinical trial 1/2007
Also Known As:
Respondin
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results